NCT06530212Completed
Sleeve Gastrectomy With Jejuno-ileal Bypass Versus Single Anastomosis Sleeve Jejunal Bypass
Sleeve Gastrectomy With Jejuno-ieal Bypass
Source: ClinicalTrials.gov · Last updated 19 Oct 2026
Brief summary (registry, in English)
sleeve gastrectomy with jejunoileal bypass (SGJIB) is a novel technique for the surgical treatment of obesity. The aim of the study is to compare this maneuver with single anastomosis sleeve jejunal bypass (SAS-JB)
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 200 (actual)
- First submitted
- 17 Jul 2024
- Start date
- 28 Sept 2024
- Primary completion date
- 20 Mar 2026
- Lead sponsor
- Minia University
- Diseases
- Obesity
- NCT number
- NCT06530212
What you commit to
- Study type: Interventional
- Participants enrolled: 200
- From 28 Sept 2024 to the primary completion date, 20 Mar 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- patients unfit for surgery
- patient with previous upper abdominal surgery either for obesity or other diseases
Age
- patients aged less than 18 and older than 60
Other
- patients refused to share in the study
- revisional bariatric procedures
Who the study is looking for
- obese patients with BMI more than 40 with or without co-morbidity or more than 35 with co-morbidity
- patients fit for laparoscopic surgery
- give approval to share in the study
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Faculty of medicine Coordinator of this site? Confirm its status | Minya | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.